GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)
INR 60.27
(-2.0%)
INR 60.27
(-2.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.27 Million INR | -85.35% |
| 2022 | 8.7 Million INR | 290.79% |
| 2021 | -4.56 Million INR | -41.19% |
| 2020 | -3.23 Million INR | -184.32% |
| 2019 | 3.83 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.27 Million INR | 385.86% |
| 2023 Q3 | 217.56 Thousand INR | -6.28% |
| 2023 Q1 | 253.1 Thousand INR | -97.31% |
| 2023 Q4 | -446.33 Thousand INR | -305.15% |
| 2023 FY | 136.47 Thousand INR | -98.43% |
| 2023 Q2 | 232.13 Thousand INR | -8.28% |
| 2022 Q2 | -390.35 Thousand INR | 0.0% |
| 2022 FY | 8.7 Million INR | 290.79% |
| 2022 Q3 | 342.2 Thousand INR | 187.66% |
| 2022 Q4 | 9.41 Million INR | 2650.98% |
| 2021 FY | -4.56 Million INR | -41.19% |
| 2020 FY | -3.23 Million INR | -184.32% |
| 2019 FY | 3.83 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 9.28 Million INR | 86.257% |
| Biocon Limited | 50.83 Billion INR | 99.997% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 99.962% |
| Concord Biotech Limited | 6.26 Billion INR | 99.98% |
| Dishman Carbogen Amcis Limited | -13.9 Million INR | 109.178% |
| FERMENTA BIOTECH LIMITED | 1.06 Billion INR | 99.881% |
| Lyka Labs Limited | 29.13 Million INR | 95.62% |
| Panacea Biotec Limited | -309.7 Million INR | 100.412% |
| SAMSRITA LABS LIMITED | -1.49 Million INR | 185.199% |
| Servoteach Industries Limited | -785.00 INR | 162615.924% |
| SMS Lifesciences India Limited | 359.47 Million INR | 99.645% |
| Supriya Lifescience Limited | 1.57 Billion INR | 99.919% |
| Syngene International Limited | 14.02 Billion INR | 99.991% |
| TAKE Solutions Limited | -213.49 Million INR | 100.598% |
| Titan Biotech Limited | 315.89 Million INR | 99.596% |
| Transgene Biotek Limited | -7.08 Million INR | 117.996% |
| Vanta Bioscience Limited | -31.83 Million INR | 104.007% |